Aphria enters into supplier agreement with Shoppers Drug Mart
Conference call December 4, 2017 at 5:30 pm ET
LEAMINGTON, ON, Dec. 4, 2017 /CNW/ – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) today announced that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart.
Subject to Health Canada’s approval of Shoppers Drug Mart’s application to be a licensed producer, under the terms of the agreement the Company will supply Shoppers Drug Mart with Aphria-branded medical cannabis products. It is expected the products will be sold online, as Canadian regulations currently restrict the sale of medical cannabis in retail pharmacies.
We have an impeccable record cultivating and producing high-quality, medical-grade cannabis . These traits make us a strong partner for an organization looking to serve and support Canadian patients.
Vic Neufeld, CEO of Aphria
CONFERENCE CALL ON DECEMBER 4, 2017
Management will hold a conference call on December 4, 2017 at 5:30 pm ET to discuss the supplier agreement between Aphria and Shoppers Drug Mart. Interested participants may take part by dialing (888) 231-8191. A replay of this call will be available until January 4, 2018 by dialing (855) 859-2056 with the passcode 6395256.
We Have a Good Thing Growing.
Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. Aphria is committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders.